SEC 13F Intelligence

Morgan Jess S & Co Inc / ORMP

Morgan Jess S & Co Inc’s Oramed Pharmaceuticals Inc Position

Does Morgan Jess S & Co Inc own Oramed Pharmaceuticals Inc (ORMP)? Yes — 366.4K shares worth $2M (+2.07% of its 13F portfolio) as of Q3 2022, up from 315.3K shares the prior filed quarter.

Position Value
$2M
Q3 2022
Shares
366.4K
% of Portfolio
+2.07%
Quarters Held
5
currently held

Position History ORMP

Reported value by quarter
Q3 ’21: $4MQ3 ’21Q4 ’21: $3MQ4 ’21Q1 ’22: $3MQ1 ’22Q2 ’22: $1MQ2 ’22Q3 ’22: $2MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022366.4K$2M+2.07%
Q2 2022315.3K$1M+1.50%
Q1 2022290.5K$3M+1.83%
Q4 2021215.4K$3M+1.89%
Q3 2021322.2K$4M+2.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Morgan Jess S & Co Inc’s full portfolio or all institutional holders of ORMP.